Evaluation of Targeting Efficiency of Joints with Anticollagen II Antibodies.
Sign Up to like & getrecommendations! Published in 2019 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.9b00059
Abstract: Diseases of the joints affect over 10% of the world's population, resulting in significant morbidity. There is an unmet need in strategies for specific delivery of therapeutics to the joints. Collagen type II is synthesized… read more here.
Keywords: collagen; targeting efficiency; times higher; evaluation targeting ... See more keywords